Effect of Cumulative Chloride Dose on Development of Acute Kidney Injury in Critically Ill Children
Public ClinicalTrials.gov record NCT02188602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Retrospective Investigation of Chloride Dosing and Its Effect on Acute Kidney Injury
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators would like to investigate the effect of chloride dosing on the development of acute kidney injury in critically ill patients. The investigators hypothesis is that administering intravenous fluids with higher chloride content are more likely to lead to acute kidney injury.
Study identification
- NCT ID
- NCT02188602
- Recruitment status
- Withdrawn
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 1 Month to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- May 31, 2015
- Completion
- May 31, 2015
- Last update posted
- Aug 21, 2022
2013 – 2015
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lucile Packard Children's Hospital | Palo Alto | California | 94303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acute Kidney Injury trials
Other public records listing Acute Kidney Injury. Sorted by last update posted; newest first. Not a recommendation.
- NCT07734636: A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury Not yet recruiting
- NCT07718464: FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids Recruiting
- NCT07683975: Infliximab for Immune Checkpoint Inhibitor Associated AKI Not yet recruiting
- NCT05805709: A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial Recruiting
- NCT07670520: Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial Recruiting
- NCT04592744: Angiotensin 2 for AKI After OLT Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02188602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 21, 2022 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02188602 live on ClinicalTrials.gov.